| - GRCh37:
- Chr17:27274843-30817038
- GRCh38:
- Chr17:28947825-32490020
| ABHD15, ADAP2, ANKRD13B, ATAD5, BLMH, C17orf75, CDK5R1, COPRS, CORO6, CPD, CRLF3, CRYBA1, EFCAB5, EVI2A, EVI2B, GIT1, GOSR1, LOC105371730, LOC106113036, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771181, LOC108771182, LOC108771183, LOC108771184, LOC108783647, LOC108783648, LOC108783652, LOC108783653, LOC110121426, LOC110806262, LOC111811965, LOC112529904, LOC112529905, LOC112529906, LOC112529907, LOC113939959, LOC113939960, LOC121587584, LOC121587585, LOC121587586, LOC125177445, LOC125177446, LOC125177447, LOC125177448, LOC125177449, LOC125177450, LOC125177451, LOC125177452, LOC125177453, LOC125177454, LOC125177455, LOC126862527, LOC126862528, LOC126862529, LOC126862530, LOC126862531, LRRC37B, MIR193A, MIR3184, MIR365B, MIR423, MIR4523, MIR4724, MIR4725, MIR4733, MIR632, MYO18A, NF1, NSRP1, NUFIP2, OMG, PHF12, PIPOX, PSMD11, RAB11FIP4, RHBDL3, RHOT1, RNF135, SEZ6, SLC6A4, SSH2, STIN2-VNTR, SUZ12, TAOK1, TBC1D29P, TEFM, TMIGD1, TP53I13, TRT-CGT4-1, UTP6, ZNF207 | | See cases | Pathogenic (Dec 10, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr17:28952286-30386515
- GRCh38:
- Chr17:30625268-32059496
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC106113036, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771181, LOC108771183, LOC108771184, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177453, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 26, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr17:28957752-30415399
- GRCh38:
- Chr17:30630734-32088380
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC106113036, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771181, LOC108771182, LOC108771184, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177453, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh38:
- Chr17:30660608-31159168
| ADAP2, ATAD5, CRLF3, LOC108281169, LOC108281170, LOC108771181, LOC108783647, LOC108783652, LOC111811965, LOC121587585, MIR4733, NF1, RNF135, TEFM | | Neurofibromatosis, type 1 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:28993036-30412788
- GRCh38:
- Chr17:30666018-32085769
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771181, LOC108771182, LOC108771184, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr17:28994990-30350877
- GRCh38:
- Chr17:30667972-32023858
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771181, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:28999834-30326958
- GRCh38:
- Chr17:30672816-31999939
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29004621-30398720
- GRCh38:
- Chr17:30677603-32071701
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771184, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Uncertain significance (Feb 14, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:29005171-30400885
- GRCh38:
- Chr17:30678153-32073866
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771184, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Mar 11, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr17:29011937-30348421
- GRCh38:
- Chr17:30684919-32021402
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Apr 30, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr17:29033863-30326952
- GRCh38:
- Chr17:30706845-31999933
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Sep 21, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr17:29033881-30321643
- GRCh38:
- Chr17:30706863-31994624
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29033882-30326958
- GRCh38:
- Chr17:30706864-31999939
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29033882-30426780
- GRCh38:
- Chr17:30706864-32099761
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771182, LOC108771184, LOC108783647, LOC108783648, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, LRRC37B, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29033882-30326958
- GRCh38:
- Chr17:30706864-31999939
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108783647, LOC108783652, LOC108783653, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Uncertain significance (Feb 14, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:29094212-30264505
- GRCh38:
- Chr17:30767194-31937486
| ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108783647, LOC108783652, LOC111811965, LOC112529907, LOC121587585, LOC121587586, LOC125177454, LOC125177455, LOC126862531, MIR193A, MIR365B, MIR4724, MIR4725, MIR4733, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, TRT-CGT4-1, UTP6 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29158338-29649192
- GRCh38:
- Chr17:30831320-31322174
| ADAP2, ATAD5, EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108783647, LOC111811965, MIR4733, NF1, OMG, RNF135, TEFM | | See cases | Uncertain significance (Mar 10, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr17:29421945-29509683
- GRCh38:
- Chr17:31094927-31182665
| LOC111811965, LOC108281169, LOC108281170, LOC108281180, NF1 | | Neurofibromatosis, type 1 | Uncertain significance (Oct 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29421945-29509683
- GRCh38:
- Chr17:31094927-31182665
| LOC108281180, LOC111811965, LOC108281169, LOC108281170, NF1 | | Neurofibromatosis, type 1 | Pathogenic (Dec 16, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29421945-29422387
- GRCh38:
- Chr17:31094927-31095369
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Pathogenic (Jan 3, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29421945-29422387
- GRCh38:
- Chr17:31094927-31095369
| NF1, LOC111811965 | | Neurofibromatosis, type 1 | Uncertain significance (Jan 10, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29421945-29704695
- GRCh38:
- Chr17:31094927-31377677
| LOC108281170, EVI2A, EVI2B, LOC108281169, LOC108281180, LOC108281181, LOC108281182, LOC111811965, LOC125177454, NF1, OMG | | Neurofibromatosis, type 1 | Pathogenic (Nov 27, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29421965
- GRCh38:
- Chr17:31094947
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422006
- GRCh38:
- Chr17:31094988
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422039-29422055
- GRCh38:
- Chr17:31095021-31095037
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422055
- GRCh38:
- Chr17:31095037
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Uncertain significance (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422055
- GRCh38:
- Chr17:31095037
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Uncertain significance (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422056
- GRCh38:
- Chr17:31095038
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Pathogenic (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422056
- GRCh38:
- Chr17:31095038
| LOC111811965, NF1 | | not provided, Neurofibromatosis, type 1 | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:29422063
- GRCh38:
- Chr17:31095045
| LOC111811965, NF1 | | Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422076-29422077
- GRCh38:
- Chr17:31095058-31095059
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422076-29422077
- GRCh38:
- Chr17:31095058-31095059
| NF1, LOC111811965 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422077
- GRCh38:
- Chr17:31095059
| LOC111811965, NF1 | | Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422082-29422083
- GRCh38:
- Chr17:31095064-31095065
| NF1, LOC111811965 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422087-29422088
- GRCh38:
- Chr17:31095069-31095070
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422091
- GRCh38:
- Chr17:31095073
| NF1, LOC111811965 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422099
- GRCh38:
- Chr17:31095081
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422119
- GRCh38:
- Chr17:31095101
| NF1, LOC111811965 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422155
- GRCh38:
- Chr17:31095137
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422162
- GRCh38:
- Chr17:31095144
| LOC111811965, NF1 | | Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422180
- GRCh38:
- Chr17:31095162
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis
| Uncertain significance (Oct 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422213
- GRCh38:
- Chr17:31095195
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422244
- GRCh38:
- Chr17:31095226
| NF1, LOC111811965 | | Neurofibromatosis, type 1, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422255
- GRCh38:
- Chr17:31095237
| NF1, LOC111811965 | | Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422277
- GRCh38:
- Chr17:31095259
| LOC111811965, NF1 | | Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422278-29701241
- GRCh38:
- Chr17:31095260-31374223
| LOC108281181, LOC111811965, LOC125177454, LOC108281170, LOC108281180, EVI2A, EVI2B, LOC108281182, LOC108281169, NF1, OMG | | Neurofibromatosis, type 1 | Pathogenic (Feb 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422306
- GRCh38:
- Chr17:31095288
| NF1, LOC111811965 | | not specified, not provided, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1
| Benign/Likely benign (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422310
- GRCh38:
- Chr17:31095292
| LOC111811965, NF1 | | Hereditary cancer-predisposing syndrome | Likely benign (Oct 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422318-29422397
- GRCh38:
- Chr17:31095300-31095379
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Pathogenic (Dec 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422318-29422397
- GRCh38:
- Chr17:31095300-31095379
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Uncertain significance (Jun 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422318-29701183
- GRCh38:
- Chr17:31095300-31374165
| EVI2A, EVI2B, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC111811965, LOC125177454, NF1, OMG | | Neurofibromatosis, type 1 | Uncertain significance (Jul 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422318-29701183
- GRCh38:
- Chr17:31095300-31374165
| OMG, EVI2B, LOC125177454, NF1, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC111811965, EVI2A | | Neurofibromatosis, type 1 | Pathogenic (Jul 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422320
- GRCh38:
- Chr17:31095302
| LOC111811965, NF1 | | Neurofibromatosis, type 1 | Uncertain significance (Aug 26, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422322-29701179
- GRCh38:
- Chr17:31095304-31374161
| LOC108281170, EVI2A, EVI2B, LOC108281169, LOC108281180, LOC108281181, LOC108281182, LOC111811965, LOC125177454, NF1, OMG | | Neurofibromatosis, type 1 | Pathogenic (Nov 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422322-29701179
- GRCh38:
- Chr17:31095304-31374161
| LOC108281170, EVI2A, EVI2B, LOC108281169, LOC108281180, LOC108281181, LOC108281182, LOC111811965, LOC125177454, NF1, OMG | | Neurofibromatosis, type 1 | Uncertain significance (Sep 19, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422322-29483150
- GRCh38:
- Chr17:31095304-31156132
| LOC111811965, NF1, LOC108281169 | | Neurofibromatosis, type 1 | Pathogenic (Oct 10, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422324
- GRCh38:
- Chr17:31095306
| LOC111811965, NF1 | | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Uncertain significance (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422325-29422329
- GRCh38:
- Chr17:31095307-31095311
| LOC111811965, NF1 | M1fs | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Pathogenic (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422326
- GRCh38:
- Chr17:31095308
| LOC111811965, NF1 | | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422326
- GRCh38:
- Chr17:31095308
| LOC111811965, NF1 | | Hereditary cancer-predisposing syndrome | Uncertain significance (May 8, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422328
- GRCh38:
- Chr17:31095310
| LOC111811965, NF1 | M1L | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
| Pathogenic (Oct 21, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422328
- GRCh38:
- Chr17:31095310
| NF1, LOC111811965 | M1L | Neurofibromatosis, type 1 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422328
- GRCh38:
- Chr17:31095310
| NF1, LOC111811965 | M1V | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1, not provided | Pathogenic (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422329
- GRCh38:
- Chr17:31095311
| LOC111811965, NF1 | M1K | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1, not provided | Pathogenic/Likely pathogenic (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422329
- GRCh38:
- Chr17:31095311
| LOC111811965, NF1 | M1R | not provided, Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype | Pathogenic (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422329
- GRCh38:
- Chr17:31095311
| LOC111811965, NF1 | M1T | not provided, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1 | Pathogenic (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422330
- GRCh38:
- Chr17:31095312
| LOC111811965, NF1 | M1I | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Pathogenic (Feb 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422330
- GRCh38:
- Chr17:31095312
| LOC111811965, NF1 | M1I | Neurofibromatosis, type 1, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome
| Pathogenic (Feb 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422331
- GRCh38:
- Chr17:31095313
| LOC111811965, NF1 | A2S | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
| Uncertain significance (Feb 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422331-29422332
- GRCh38:
- Chr17:31095313-31095314
| LOC111811965, NF1 | A2F | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
| Uncertain significance (Jul 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422332
- GRCh38:
- Chr17:31095314
| LOC111811965, NF1 | A2D | Neurofibromatosis, type 1 | Uncertain significance (Dec 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422332
- GRCh38:
- Chr17:31095314
| LOC111811965, NF1 | A3fs | Neurofibromatosis, type 1 | Pathogenic (Oct 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422332
- GRCh38:
- Chr17:31095314
| LOC111811965, NF1 | A2V | Hereditary cancer-predisposing syndrome | Uncertain significance (Jan 12, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422333
- GRCh38:
- Chr17:31095315
| LOC111811965, NF1 | | Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype
| Likely benign (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422333
- GRCh38:
- Chr17:31095315
| LOC111811965, NF1 | | Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1, not provided
| Likely benign (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422334
- GRCh38:
- Chr17:31095316
| LOC111811965, NF1 | A3T | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
| Uncertain significance (Feb 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422335
- GRCh38:
- Chr17:31095317
| LOC111811965, NF1 | A3E | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422335
- GRCh38:
- Chr17:31095317
| LOC111811965, NF1 | A3G | Neurofibromatosis, type 1 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422335
- GRCh38:
- Chr17:31095317
| LOC111811965, NF1 | A3V | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, type 1
| Uncertain significance (Dec 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422336
- GRCh38:
- Chr17:31095318
| LOC111811965, NF1 | | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
| Likely benign (Apr 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422336
- GRCh38:
- Chr17:31095318
| LOC111811965, NF1 | H4fs | Neurofibromatosis, type 1 | Pathogenic (Nov 25, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422337
- GRCh38:
- Chr17:31095319
| NF1, LOC111811965 | H4fs | Neurofibromatosis, type 1 | Pathogenic (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422337
- GRCh38:
- Chr17:31095319
| LOC111811965, NF1 | H4Y | Neurofibromatosis, type 1 | Uncertain significance (Sep 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422337
- GRCh38:
- Chr17:31095319
| LOC111811965, NF1 | H4N | Neurofibromatosis, type 1 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422339
- GRCh38:
- Chr17:31095321
| LOC111811965, NF1 | | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Likely benign (Mar 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422340
- GRCh38:
- Chr17:31095322
| LOC111811965, NF1 | | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Likely benign (Nov 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422340
- GRCh38:
- Chr17:31095322
| LOC111811965, NF1 | R5G | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, type 1
| Uncertain significance (Aug 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422340
- GRCh38:
- Chr17:31095322
| LOC111811965, NF1 | R5W | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Uncertain significance (Sep 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422341
- GRCh38:
- Chr17:31095323
| LOC111811965, NF1 | R5fs | Neurofibromatosis, type 1 | Pathogenic (Jan 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422342
- GRCh38:
- Chr17:31095324
| NF1, LOC111811965 | | Neurofibromatosis, type 1 | Likely benign (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422342
- GRCh38:
- Chr17:31095324
| LOC111811965, NF1 | R5S | Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1
| Uncertain significance (Apr 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422343
- GRCh38:
- Chr17:31095325
| NF1, LOC111811965 | P6S | not provided | Uncertain significance (Apr 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422344
- GRCh38:
- Chr17:31095326
| LOC111811965, NF1 | P6Q | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422344
- GRCh38:
- Chr17:31095326
| NF1, LOC111811965 | P6R | not provided, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Neurofibromatosis, type 1 | Uncertain significance (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422344
- GRCh38:
- Chr17:31095326
| LOC111811965, NF1 | P6L | Juvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis-Noonan syndrome, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1 | Uncertain significance (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:29422346
- GRCh38:
- Chr17:31095328
| LOC111811965, NF1 | V7M | Neurofibromatosis, type 1 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422347-29422350
- GRCh38:
- Chr17:31095329-31095332
| LOC111811965, NF1 | V7fs | Neurofibromatosis, type 1 | Pathogenic (Feb 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422349-29422350
- GRCh38:
- Chr17:31095331-31095332
| LOC111811965, NF1 | E8fs | Neurofibromatosis, type 1 | Pathogenic (Aug 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422353-29422359
- GRCh38:
- Chr17:31095335-31095341
| LOC111811965, NF1 | V10fs | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Pathogenic (Aug 20, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:29422353
- GRCh38:
- Chr17:31095335
| LOC111811965, NF1 | W9L | Neurofibromatosis, type 1 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |